ISMP Announces 27th Annual Cheers Award Recipients
ISMP Announces 27th Annual Cheers Award Recipients
Awardees Focused on Vaccine Safety, Opioid Management, Technology
獲獎者專注於生物-疫苗安全、阿片類藥物管理和科技
PLYMOUTH MEETING, Pa., Nov. 19, 2024 /PRNewswire/ -- The Institute for Safe Medication Practices (ISMP) is proud to announce the 27th Annual Cheers Award winners, who have worked to significantly reduce vaccine-related errors and improve opioid management, and the Michael R. Cohen Lifetime Award winner whose groundbreaking work has confirmed how technology such as computerized order entry (CPOE) can help advance medication safety.
美國賓夕法尼亞州普利茅斯會議,2024年11月19日 /PRNewswire/ -- 安全用藥實踐研究所(ISMP)自豪地宣佈第27屆Cheers獎獲獎者,他們在顯著減少生物-疫苗相關錯誤和改善阿片類藥物管理方面做出了貢獻,同時還有邁克爾·R·cohen終身成就獎獲獎者,其開創性工作證實瞭如計算機化醫囑錄入(CPOE)等科技如何幫助提高用藥安全。
The awards ceremony will be held on Tuesday, December 10, 2024, at the Civic Theater in New Orleans. The annual ISMP Cheers Awards honor individuals, organizations, and companies that have set a standard of excellence in medication safety; for more information, visit: .
頒獎典禮將於2024年12月10日(星期二)在新奧爾良的身份幣劇院舉行。年度ISMP Cheers獎表彰那些在用藥安全方面樹立卓越標準的個人、組織和公司;有關更多信息,請訪問:。
27th Annual ISMP Cheers Award winners focused on vaccine safety, opioid management, and technology
第27屆年度ISMP Cheers獎獲獎者專注於生物-疫苗安全、阿片類藥物管理和科技
"This year's ISMP Cheers Award winners are ahead of the curve in terms of finding innovative ways to use technology to prevent medication errors," says ISMP President Rita K. Jew. "These dedicated organizations and leaders set a high bar for the rest of the healthcare community to emulate."
「今年的ISMP Cheers獎獲獎者在尋找創新方式利用科技來防止用藥錯誤方面走在前列,」ISMP主席麗塔·K·朱說道。「這些敬業的組織和領導者爲其他醫療保健社區設定了高標準。」
The winners of this year's ISMP Cheers Awards are:
今年ISMP Cheers獎的獲獎者是:
-
Cook Children's Health Care System
Fort Worth, TX
The Quality Improvement Team at Cook Children's Health Care System is receiving a Cheers Award for significantly reducing the number of vaccine errors within their pediatric network. The team was formed to address errors related to immunizations, especially those involving complex vaccine age eligibility and vaccine series interval timing. They collaborated with the information technology department to integrate a clinical decision support tool into the electronic medical record system that alerts healthcare providers to potential errors in real time. Since it was implemented, more than 9,000 inappropriate vaccine orders have been successfully averted by following the guidance provided by the clinical alerts. A substantial decrease in error rates was noted for most vaccines, with the most pronounced decline for the hepatitis A series, which achieved an impressive 91% reduction. The team also implemented a dashboard-based monitoring system for patient safety to ensure continuous improvement and oversight.
-
Hospital for Sick Children (SickKids)
Toronto, Canada
The Perioperative Opioid Stewardship Research Program (PROSPR) at the Hospital for Sick Children in Toronto is being honored for improving the way opioids are managed during post-surgery hospital discharge. The program aims to address overprescribing of opioids in pediatrics, minimize the volume of unnecessary opioids entering the community, and decrease the volume of unused opioids. The program team identified risks, modified practice standards, re-evaluated processes, and expanded their reach to other diagnoses. Their achievements include using technology and QI methodology to safely decrease the amount of unused opioids retained by patients from 83% to 17% and creating a new pathway to facilitate the return and disposal of unused opioids. They also addressed language barriers and improved access by translating all educational documentation into the ten most used languages in their surgical population, allowing more families to participate.
-
庫克兒童醫療體系
德克薩斯州沃斯堡
庫克兒童醫療保健系統的質量改進團隊因在其兒科網絡內顯著減少疫苗錯誤而獲得Cheers獎。該團隊成立的目的是解決與免疫接種相關的錯誤,特別是涉及複雜疫苗年齡資格和疫苗系列間隔時機的錯誤。他們與信息技術部門合作,將臨床決策支持工具集成到電子病歷系統中,實時提醒醫療提供者潛在的錯誤。自實施以來,遵循臨床警報提供的指導,成功避免了超過9,000個不當疫苗訂單。大多數疫苗的錯誤率顯著降低,以乙型肝炎系列的下降幅度最爲明顯,達到了91%的顯著減少。該團隊還實施了基於儀表板的患者安全監測系統,以確保持續改進和監督。
-
多倫多兒童醫院 (SickKids)
加拿大多倫多
多倫多兒童醫院的圍手術期阿片類藥物管理研究項目 (PROSPR) 因改善術後住院出院期間阿片類藥物的管理而受到表彰。該項目旨在解決兒科護士對阿片類藥物的過度處方,最小化進入社區的多餘阿片類藥物的營業收入,並減少未使用阿片類藥物的營業收入。項目團隊識別風險,修改實踐標準,重新評估流程,並擴大其對其他診斷的覆蓋範圍。他們的成就包括利用科技和質量改進方法,安全地將患者保留的未使用阿片類藥物數量從83%減少到17%,並創建新的途徑以促進未使用阿片類藥物的退還和處理。他們還解決了語言障礙,通過將所有教育文件翻譯成在其外科人群中使用最廣泛的十種語言,改善了訪問的便利性,使更多家庭能夠參與。
The Michael R. Cohen Lifetime Achievement Award is being presented to David W. Bates, M.D, M.Sc., an internationally renowned safety expert, for his groundbreaking work evaluating the incidence and preventability of adverse drug events and harm from medications. He has demonstrated that information technology such as CPOE and clinical decision support can decrease the risk of serious medication errors, and his research has been referred to in Health Care Financing Administration regulations, the Medicare Patient Advisory Commission's 1999 Report to Congress, and the Institute of Medicine's report To Err is Human. CPOE is now being implemented in health systems and facilities across the U.S. He has published more than 1,200 peer-reviewed papers that have been cited over 155,000 times and is among the 400 most cited biomedical researchers. He currently is the Medical Director of Clinical and Quality Analysis at Mass General Brigham, a Senior Physician at Brigham and Women's Hospital (BWH), and directs the Center for Patient Safety Research and Practice at BWH, which focuses on improving medication safety across the continuum of care and patient groups. Dr. Bates also is a professor at both Harvard Medical School and at the Harvard T.H. Chan School of Public Health and the editor of the Journal of Patient Safety. Dr. Bates has received multiple awards, including the first John M. Eisenberg Award for excellence in patient safety research from the National Quality Forum and the Henry Christian Award for excellence in research from the American Federation for Clinical Research.
邁克爾·R·科恩終身成就獎頒給大衛·W·貝茨萬.D萬.Sc.,這位國際知名的安全專家,表彰他在評估不良藥物事件和藥物傷害的發生率及其可預防性方面的開創性工作。他已經證明,信息科技如CPOE和臨床決策支持可以減少嚴重用藥錯誤的風險,他的研究被引用於醫療保健融資管理局的規定、1999年醫療保險患者諮詢委員會提交國會的報告以及醫學研究院的《錯誤是人類》中。CPOE目前正在美國的衛生系統和設施中實施。他發表了超過1200篇經過同行評審的論文,被引用超過155,000次,屬於400位被引用最多的生物醫藥研究者之一。他目前是馬薩諸塞州總醫院的臨床和質量分析醫學主任,是布萊根和婦女醫院(BWH)的高級醫師,並負責BWH患者安全研究與實踐中心,專注於改善整個護理過程和患者群體的用藥安全。貝茨博士也是哈佛醫學院和哈佛t.H.陳公共衛生學院的教授,以及《患者安全雜誌》的編輯。貝茨博士獲得了多項獎項,包括國家質量論壇頒發的第一屆約翰·m·艾森博格獎以表彰在患者安全研究中的卓越成就,以及美國臨床研究聯合會頒發的亨利·克里斯蒂安獎以表彰研究中的卓越成就。
"The Cheers Awards winners demonstrate how to make impressive advances in medication safety using innovative system-based solutions," Dheerendra Kommala, M.D., chief medical officer at ECRI, ISMP's affiliate organization. "We applaud their commitment to safety and ensuring quality patient care."
ECRI的首席醫學官Dheerendra Kommala萬.D.表示:「Cheers獎的獲獎者展示瞭如何通過創新系統解決方案在用藥安全方面取得顯著進展。我們讚賞他們對安全和確保優質患者護理的承諾。」
About the Institute for Safe Medication Practices
The Institute for Safe Medication Practices (ISMP) is the nation's first 501c (3) nonprofit organization devoted entirely to preventing medication errors. ISMP is known and respected for its medication safety information. For more than 25 years, it also has served as a vital force for progress. ISMP's advocacy work alone has resulted in numerous necessary changes in clinical practice, public policy, and drug labeling and packaging. Among its many initiatives, ISMP runs the only national voluntary practitioner medication error reporting program, publishes newsletters with real-time error information read and trusted throughout the global healthcare community, and offers a wide range of unique educational programs, tools, and guidelines. In 2020, ISMP formally affiliated with ECRI to create one of the largest healthcare quality and safety entities in the world, and ECRI and the ISMP PSO is a federally certified patient safety organization by the U.S. Department of Health and Human Services. As a watchdog organization, ISMP receives no advertising revenue and depends entirely on charitable donations, educational grants, newsletter subscriptions, and volunteer efforts to pursue its life-saving work. Visit and follow @ismp_org to learn more.
關於安全用藥實踐研究所
安全用藥實踐研究所(ISMP)是全國首家501c(3)非營利組織,專門致力於防止用藥錯誤。ISMP因其用藥安全信息而享有聲譽和尊重。25年來,它也一直是進步的重要力量。單是ISMP的倡導工作就已導致臨床實踐、公共政策、藥物標籤和包裝的諸多必要變更。在其衆多倡議中,ISMP運營着唯一的全國自願從業者用藥錯誤報告程序,發佈實時錯誤信息的通訊,該信息在全球醫療社區中廣受信賴,並提供廣泛獨特的教育項目、工具和指南。2020年,ISMP正式與ECRI聯合,創造了全球最大醫療質量和安全實體之一,ECRI和ISMP PSO由美國衛生與公共服務部認證爲聯邦患者安全組織。作爲一個監督組織,ISMP不接受任何廣告收入,完全依賴慈善捐贈、教育贈款、通訊訂閱和志願者的努力來推進其拯救生命的工作。訪問並關注@ismp_org了解更多。
SOURCE Institute for Safe Medication Practices
來源:安全用藥實踐研究所
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
想要您公司的新聞在PRNEWSWIRE.COM上特色呈現嗎?
譯文內容由第三人軟體翻譯。